MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 24 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | -94.3% | 1,097 | -93.7% | 0.00% | – |
| Q1 2020 | $35,000 | – | 17,306 | +29737.9% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 58 | -99.1% | 0.00% | – |
| Q2 2019 | $26,000 | 0.0% | 6,300 | -0.2% | 0.00% | – |
| Q1 2019 | $26,000 | +36.8% | 6,314 | -3.1% | 0.00% | – |
| Q4 2018 | $19,000 | -72.9% | 6,514 | -7.6% | 0.00% | – |
| Q3 2018 | $70,000 | – | 7,049 | +176125.0% | 0.00% | – |
| Q2 2017 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
| Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
| Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
| Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
| ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
| Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
| Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
| Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
| Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |